Bharat Biotech and GSK plc will significantly reduce the price of their malaria vaccine, Mosquirix, to under $5 per dose by ...

Adults on dupilumab for severe chronic rhinosinusitis with nasal polyps had better outcomes than those who used omalizumab, ...

With the newly formed federal vaccine advisory committee poised to reevaluate childhood vaccine mandates, Gov. Josh Shapiro on Wednesday urged Health and Human Services Secretary Robert F. Kennedy Jr.

GSK PLC GSK shares slid 1.10% to £13.95 Wednesday, on what proved to be an all-around poor trading session for the stock ...

As part of a multi-year collaboration, GSK and India’s Bharat Biotech are redoubling their efforts to bring the world’s first malaria vaccine to more countries in need at affordable prices. | The ...

Note that some links may require registration or subscription. Ahead of a 2-day meeting of the Advisory Committee on ...

The Pharmaceutical Automation and Digitalisation Congress (AUTOMA+) 2025 welcomes delegates to be a part of its 5th ...

Drugmakers Bharat Biotech and GSK will cut the price of their malaria vaccine to below $5 per dose by 2028, more than halving ...

Vasculitis, a severe blood vessel condition, drives the global market's growth due to advancements in biologic treatments like monoclonal antibodies. Enhanced diagnostics and personalized medicine ...

Eddie Gray, veteran pharma and vaccine industry leader, has joined the Botanical Solution Inc. (BSI) Board of Directors.